Danaher Corporation to Acquire Masimo Corporation for $9.9B

Washington, February 17, 2026 (PRNewswire) -- Danaher Corporation announced it has signed a definitive agreement to acquire Masimo Corporation, a leader in pulse oximetry and advanced patient monitoring technologies, in an all-cash deal valued at approximately $9.9 billion, including assumed debt.

Under the agreement, Danaher will pay $180 per share in cash, representing a transaction multiple of roughly 18x estimated 2027 EBITDA, or 15x including expected synergies.

Masimo will operate as a standalone company within Danaher’s Diagnostics segment, joining businesses such as Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter Diagnostics.

Read full article here.